相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis
Adrian Ciurea et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data
Tae-Jong Kim et al.
JOINT BONE SPINE (2016)
Effects of tumor necrosis factor-α inhibitors on new bone formation in ankylosing spondylitis
Jing-Ru Zhang et al.
JOINT BONE SPINE (2016)
Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study
Fiona Maas et al.
PLOS ONE (2015)
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Juergen Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
Peggy Jacques et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The presence of peripheral arthritis delays spinal radiographic progression in ankylosing spondylitis: Observation Study of the Korean Spondyloarthropathy Registry
Tae-Jong Kim et al.
RHEUMATOLOGY (2014)
Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification
Walter P. Maksymowych et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Evidence in support of the validity of the TNF brake hypothesis
Walter P. Maksymowych
ANNALS OF THE RHEUMATIC DISEASES (2013)
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Continuous NSAID use reverts the effects of in ammation on radiographic progression in patients with ankylosing spondylitis
Feline Kroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis
Denis Poddubnyy et al.
ARTHRITIS AND RHEUMATISM (2012)
Serum leptin levels are associated with the presence of syndesmophytes in male patients with ankylosing spondylitis
Ki-Jo Kim et al.
CLINICAL RHEUMATOLOGY (2012)
Increased Body Mass Index in Ankylosing Spondylitis Is Associated with Greater Burden of Symptoms and Poor Perceptions of the Benefits of Exercise
Laura Durcan et al.
JOURNAL OF RHEUMATOLOGY (2012)
Body mass index influences the response to infliximab in ankylosing spondylitis
Sebastien Ottaviani et al.
ARTHRITIS RESEARCH & THERAPY (2012)
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
Determinants of Early Radiographic Progression in Ankylosing Spondylitis
Pamir Atagunduz et al.
JOURNAL OF RHEUMATOLOGY (2010)
Disease modification in ankylosing spondylitis
Walter P. Maksymowych
NATURE REVIEWS RHEUMATOLOGY (2010)
Inflammatory Lesions of the Spine on Magnetic Resonance Imaging Predict the Development of New Syndesmophytes in Ankylosing Spondylitis
Walter P. Maksymowych et al.
ARTHRITIS AND RHEUMATISM (2009)
Clinical and Immunogenetic Prognostic Factors for Radiographic Severity in Ankylosing Spondylitis
Michael M. Ward et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
The Natural Course of Radiographic Progression in Ankylosing Spondylitis - Evidence for Major Individual Variations in a Large Proportion of Patients
Xenofon Baraliakos et al.
JOURNAL OF RHEUMATOLOGY (2009)
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
Desiree van der Heijde et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
Xenofon Baraliakos et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab
X. Baraliakos et al.
RHEUMATOLOGY (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis
M-C Park et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab -: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study
J Braun et al.
ARTHRITIS AND RHEUMATISM (2006)
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
JC Davis et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor a antibody infliximab
X Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Evaluation of clinical activity and functional impairment in smokers with Ankylosing spondylitis
U Kaan et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis -: A randomized clinical trial
A Wanders et al.
ARTHRITIS AND RHEUMATISM (2005)
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
MCW Creemers et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD
HJ Baek et al.
RHEUMATOLOGY (2004)
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis -: An open, observational, extension study of a three-month, randomized, placebo-controlled trial
J Braun et al.
ARTHRITIS AND RHEUMATISM (2003)
分享论文
